| Incidence and prevalence of multiple sclerosis in Europe: a systematic review E Kingwell, JJ Marriott, N Jetté, T Pringsheim, N Makhani, SA Morrow, ... BMC neurology 13, 1-13, 2013 | 758 | 2013 |
| Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis A Shirani, Y Zhao, ME Karim, C Evans, E Kingwell, ML Van Der Kop, ... Jama 308 (3), 247-256, 2012 | 345 | 2012 |
| Incidence and prevalence of multiple sclerosis in the Americas: a systematic review C Evans, SG Beland, S Kulaga, C Wolfson, E Kingwell, J Marriott, M Koch, ... Neuroepidemiology 40 (3), 195-210, 2013 | 307 | 2013 |
| The natural history of secondary progressive multiple sclerosis M Koch, E Kingwell, P Rieckmann, H Tremlett Journal of Neurology, Neurosurgery & Psychiatry 81 (9), 1039-1043, 2010 | 251 | 2010 |
| The natural history of primary progressive multiple sclerosis M Koch, E Kingwell, P Rieckmann, H Tremlett Neurology 73 (23), 1996-2002, 2009 | 238 | 2009 |
| Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada E Kingwell, M Van der Kop, Y Zhao, A Shirani, F Zhu, J Oger, H Tremlett Journal of Neurology, Neurosurgery & Psychiatry 83 (1), 61-66, 2012 | 217 | 2012 |
| Physical activity, body mass index and bone mineral density—associations in a prospective population-based cohort of women and men: The Canadian Multicentre Osteoporosis Study … L Langsetmo, CL Hitchcock, EJ Kingwell, KS Davison, C Berger, ... Bone 50 (1), 401-408, 2012 | 192 | 2012 |
| High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991–2010) E Kingwell, F Zhu, RA Marrie, JD Fisk, C Wolfson, S Warren, ... Journal of neurology 262, 2352-2363, 2015 | 169 | 2015 |
| Age related multiple sclerosis severity score: disability ranked by age A Manouchehrinia, H Westerlind, E Kingwell, F Zhu, R Carruthers, ... Multiple Sclerosis Journal 23 (14), 1938-1946, 2017 | 156 | 2017 |
| Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study JMA Wijnands, E Kingwell, F Zhu, Y Zhao, T Högg, K Stadnyk, O Ekuma, ... The Lancet Neurology 16 (6), 445-451, 2017 | 151 | 2017 |
| Cancer risk in multiple sclerosis: findings from British Columbia, Canada E Kingwell, C Bajdik, N Phillips, F Zhu, J Oger, S Hashimoto, H Tremlett Brain 135 (10), 2973-2979, 2012 | 125 | 2012 |
| Five years before multiple sclerosis onset: phenotyping the prodrome JMA Wijnands, F Zhu, E Kingwell, Y Zhao, O Ekuma, X Lu, C Evans, ... Multiple Sclerosis Journal 25 (8), 1092-1101, 2019 | 118 | 2019 |
| Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS E Kingwell, M Koch, B Leung, S Isserow, J Geddes, P Rieckmann, ... Neurology 74 (22), 1822-1826, 2010 | 117 | 2010 |
| Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study JMA Wijnands, F Zhu, E Kingwell, JD Fisk, C Evans, RA Marrie, Y Zhao, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (10), 1050-1056, 2018 | 111 | 2018 |
| Infection-related health care utilization among people with and without multiple sclerosis JMA Wijnands, E Kingwell, F Zhu, Y Zhao, JD Fisk, C Evans, RA Marrie, ... Multiple Sclerosis Journal 23 (11), 1506-1516, 2017 | 107 | 2017 |
| Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis T Zhang, H Tremlett, S Leung, F Zhu, E Kingwell, JD Fisk, V Bhan, ... Neurology 86 (14), 1287-1295, 2016 | 105 | 2016 |
| Effects of physical comorbidities on disability progression in multiple sclerosis T Zhang, H Tremlett, F Zhu, E Kingwell, JD Fisk, V Bhan, T Campbell, ... Neurology 90 (5), e419-e427, 2018 | 91 | 2018 |
| Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort ME Karim, P Gustafson, J Petkau, Y Zhao, A Shirani, E Kingwell, C Evans, ... American journal of epidemiology 180 (2), 160-171, 2014 | 84 | 2014 |
| Predicting risk of secondary progression in multiple sclerosis: a nomogram A Manouchehrinia, F Zhu, D Piani-Meier, M Lange, DG Silva, ... Multiple Sclerosis Journal 25 (8), 1102-1112, 2019 | 77 | 2019 |
| Adherence and persistence to drug therapies for multiple sclerosis: a population-based study C Evans, RA Marrie, F Zhu, S Leung, X Lu, DY Melesse, E Kingwell, ... Multiple Sclerosis and Related Disorders 8, 78-85, 2016 | 76 | 2016 |
